Sirona Biochem Corp. (CVE:SBM – Get Free Report) traded down 7.7% during trading on Wednesday . The company traded as low as C$0.06 and last traded at C$0.06. 120,500 shares were traded during mid-day trading, an increase of 54% from the average session volume of 78,054 shares. The stock had previously closed at C$0.07.
Sirona Biochem Trading Down 15.4 %
The company has a quick ratio of 2.41, a current ratio of 0.34 and a debt-to-equity ratio of 219.21. The company has a market cap of C$14.13 million, a price-to-earnings ratio of -5.50 and a beta of -0.03. The firm has a 50 day moving average price of C$0.06 and a two-hundred day moving average price of C$0.07.
About Sirona Biochem
Sirona Biochem Corp., a cosmetic ingredient and drug discovery company, develops and sells cosmetic and pharmaceutical active ingredients in Canada and France. Its programs include cosmetic skin lightener and diabetes drug; and other projects comprise the development of an anti-aging/cell protection library, novel anti-wrinkle compound, and anti-viral program.
Further Reading
- Five stocks we like better than Sirona Biochem
- Pros And Cons Of Monthly Dividend Stocks
- Corporate Crawl: Where Business Trips Turn Into Party Nights
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- CrowdStrike’s Growth Remains Strong—Buy While It’s Down
- Retail Stocks Investing, Explained
- Is Advanced Micro Devices Stock Slide Over?
Receive News & Ratings for Sirona Biochem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sirona Biochem and related companies with MarketBeat.com's FREE daily email newsletter.
